港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

生物医药B类股

570.136

-12.792-2.19%

涨家数：7

跌家数：26

平家数：1

市盈率：- -

高：587.289

开：582.929

低：558.320

收：582.929

数据加载中...

贝康医疗-B盘中异动股价大涨10.45%

港股异动 | 再鼎医药(09688)尾盘涨近5% ZL-1310数据亮眼机构指后续或有多个催化剂

终于没人diss创新药了

雅本化学(300261.SZ)：目前尚未涉及创新药业务的投资布局

康诺亚亏损加剧再筹8.64亿输血，核心产品医保谈判成破局关键

中金升亚盛医药(06855.HK)目标价至69港元APG-2575数据亮眼

A股午评：沪指收涨0.54% 再度站上3400点创新药板块回调

A股化学制药板块震荡回调，海辰药业、永安药业均跌超9%，一品红、哈三联、通化金马、翰宇药业、河化股份等均跌5%。

药明康德在上海成立医药研发公司注册资本500万

南方财经网

A股创新药概念震荡回调，联化科技盘中触及跌停，万邦德、哈三联、万邦医药、舒泰神跌超5%，翰宇药业、益方生物等跟跌。

李氏大药厂盘中异动快速上涨5.23%报1.610港元

荣昌生物盘中异动早盘股价大涨5.01%报50.350港元

中国抗体-B(03681)上涨6.35%，报2.68元/股

开拓药业-B盘中异动早盘股价大涨5.30%

康方生物“双面承压”：抗癌药陷合规风波，临床数据再引争议

绿谷医药停产阿尔茨海默病治疗药物三重质疑下的破冰者终陷困局

康诺亚-B(02162)、Moonshot Holdings Limited与牵头账簿管理人及联席账簿管理人订立配售及认购协议

智通财经网

开源晨会0611丨美图公司、方盛制药、再鼎医药、绿城中国等

开源证券研究所

【湖南省提前完成年度医保基金清算】据国家医保局消息，近日，湖南省医保部门宣布，全省15个统筹区提前1个月完成上年度医保基金清算工作，共向3.1万家定点医药机构拨付清算资金92.2亿元。

默沙东RSV单抗获FDA批准上市，和誉医药新药、丽珠医药siRNA疗法新进展

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":570.13635,"timestamp":1749802087763,"preClose":582.92883,"halted":0,"volume":380175488,"delay":0,"changeRate":-0.021945,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-12.79248,"latestTime":"06-13 16:00:00","open":582.92883,"high":587.289,"low":558.3201,"amount":8643935996,"amplitude":0.049695,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1750037400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749778200000,1749787200000],[1749790800000,1749801600000]],"pbRate":4.775053,"peRate":-29.406123,"turnoverRate":0.014292,"increases":7,"decrements":26,"flats":0,"marketCap":332995831168,"floatMarketCap":305114398560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":587.289,"amplitude":0.049695,"preClose":582.92883,"low":558.3201,"pbRate":"4.775053","latestPrice":570.13635,"volume":380175488,"delay":0,"open":582.92883,"prevYearClose":331.1933,"prevWeekClose":504.495,"prevMonthClose":491.683,"prevQuarterClose":455.082,"fiveDayClose":504.495,"twentyDayClose":454.964,"sixtyDayClose":426.424,"secType":"PLATE","market":"HK","turnoverRate":0.014292,"peRate":-29.406123,"marketCap":332995831168,"floatMarketCap":305114398560,"timestamp":1749802087763,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":26,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542033143","title":"贝康医疗-B盘中异动 股价大涨10.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542033143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542033143?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 15:42","pubTimestamp":1749627743,"startTime":"0","endTime":"0","summary":"2025年06月11日临近收盘15时42分，贝康医疗-B股票出现异动，股价急速拉升10.45%。截至发稿，该股报3.170港元/股，成交量2.1万股，换手率0.03%，振幅13.24%。贝康医疗-B股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，方达控股、基石药业-B、科济药业-B涨幅较大，振幅较大的相关个股有北海康成-B、方达控股、中国抗体-B，振幅分别为21.23%、18.42%、16.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611154223977a94ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611154223977a94ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1597","BK1222","02170","BK1574"],"gpt_icon":0},{"id":"2542370043","title":"港股异动 | 再鼎医药(09688)尾盘涨近5% ZL-1310数据亮眼 机构指后续或有多个催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2542370043","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542370043?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 15:23","pubTimestamp":1749626615,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药尾盘涨近5%，截至发稿，涨4.21%，报32.15港元，成交额3.35亿港元。消息面上，再鼎医药近日公布有关ZL-1310的正面数据，加上美国FDA已授出快速通道认证，集团计划今年下半年开展第二类小细胞肺癌的第三阶段关键研究。美银表示，基于以上临床进展，将集团2027年收入及净利润预测分别上调2.5%及14%。年内后续ZL-1310催化剂包括：2L+ SCLC关键注册性临床有望于2H25开启，预计将以1.6mg/kg作为剂量，1LSCLC数据读出，潜在出海授权机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK1161","BK4526","BK4585","ZLAB","LU2488822045.USD","BK4531","09688","BK4139","BK1588","BK4588","BK1574"],"gpt_icon":0},{"id":"2542830830","title":"终于没人diss创新药了","url":"https://stock-news.laohu8.com/highlight/detail?id=2542830830","media":"韭圈儿","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542830830?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 15:15","pubTimestamp":1749626151,"startTime":"0","endTime":"0","summary":"最新的数据显示，今年收益率排行榜前十的基金里，除排在第九的中信建投北交所疑似采用小微盘策略外，其他的已经全面由创新药基金霸榜了。目前排行榜的情况，汇添富张韡和长城梁福睿大幅领跑，估计他们二人要争创新药板块的冠亚军了。医保局计划推出专为创新药设立丙类目录，优化集采规则。当然，2020年那波主攻的CXO和疫苗，这次只能做创新药的陪衬了。最著名的就是万民远关于创新药透支估值的评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611152031a7034254&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611152031a7034254&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1593","03692","01530","BK1161","06978"],"gpt_icon":0},{"id":"2542637018","title":"雅本化学(300261.SZ)：目前尚未涉及创新药业务的投资布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2542637018","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542637018?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 15:09","pubTimestamp":1749625757,"startTime":"0","endTime":"0","summary":"格隆汇6月11日丨雅本化学(300261.SZ)在互动平台表示，公司核心业务聚焦于创新农药中间体、创新医药中间体的CDMO服务，可根据客户需求提供分析研发、小试工艺开发、中试放大生产等解决方案，为合作伙伴提供定制化、高效率的中间体研发与生产支持。公司目前尚未涉及创新药业务的投资布局，业务重心始终围绕中间体领域的技术创新与服务升级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/11150951001146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300261","BK1161","BK1574","BK0174","BK0229","06978","159992","BK0028"],"gpt_icon":0},{"id":"2542377179","title":"康诺亚亏损加剧再筹8.64亿输血，核心产品医保谈判成破局关键","url":"https://stock-news.laohu8.com/highlight/detail?id=2542377179","media":"财中社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542377179?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 14:48","pubTimestamp":1749624480,"startTime":"0","endTime":"0","summary":"相比之下，尚未进入医保的司普奇拜单抗商业化定价为每支1659元，患者用药成本显著高于竞品。2025年医保谈判将成为决定该产品市场表现的关键因素。高研发投入及销售团队建设需持续输血，盈利拐点取决于核心产品的医保准入及市场教育成效。康诺亚-B虽通过条款设计部分缓释风险，但系统性挑战仍需核心产品商业化成功方能破局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061114492195176a3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061114492195176a3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1574","BK1587","BK1583","BK1161"],"gpt_icon":0},{"id":"2542746653","title":"中金升亚盛医药(06855.HK)目标价至69港元APG-2575数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2542746653","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542746653?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 13:57","pubTimestamp":1749621445,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","CNHmain","APG","MCNHmain","CYB","BK4129","LU1923622291.USD","LU2125909759.SGD","AAPG","06855","BK4139","UCmain","MUCmain","LU2125909916.SGD","BK1574"],"gpt_icon":0},{"id":"2542375599","title":"A股午评：沪指收涨0.54% 再度站上3400点 创新药板块回调","url":"https://stock-news.laohu8.com/highlight/detail?id=2542375599","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542375599?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 11:38","pubTimestamp":1749613092,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603982","399006","159715","600366","06978","BK0214","BK1161","BK0086","BK0229","BK0070","BK0233","002250","603335","BK1574","BK0235","BK0251","600281","605151","159982","399300","BK0010","BK0066","BK0028","BK0264","603586","399001","159992","BK0118","BK0188","301141","BK0084","600980","399366"],"gpt_icon":0},{"id":"2542373605","title":"A股化学制药板块震荡回调，海辰药业、永安药业均跌超9%，一品红、哈三联、通化金马、翰宇药业、河化股份等均跌5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542373605","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542373605?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 11:12","pubTimestamp":1749611539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0071","BK0066","300199","399300","000766","BK0010","BK0188","BK0239","BK0004","01477","159982","BK1191","300584","BK0060","BK0028","BK1574","002365","BK0077","002900","300723","BK0070","BK0086","000953"],"gpt_icon":0},{"id":"2542375327","title":"药明康德在上海成立医药研发公司 注册资本500万","url":"https://stock-news.laohu8.com/highlight/detail?id=2542375327","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542375327?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 11:10","pubTimestamp":1749611443,"startTime":"0","endTime":"0","summary":"南方财经6月11日电，天眼查App显示，近日，药明康德（上海）医药研发有限公司成立，法定代表人为张朝晖，注册资本500万人民币，经营范围为技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广，货物进出口，技术进出口，医学研究和试验发展，信息咨询服务。股东信息显示，该公司由药明康德（603259）全资持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506113427595713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","LU2045819591.USD","LU2125910500.SGD","BK1141","LU1046422090.SGD","BK1583","LU0320764599.SGD","BK1574","BK1576","LU0052750758.USD","LU0708995583.HKD","09939","BK1161","BK1515","LU2242644610.SGD"],"gpt_icon":0},{"id":"2542788473","title":"A股创新药概念震荡回调，联化科技盘中触及跌停，万邦德、哈三联、万邦医药、舒泰神跌超5%，翰宇药业、益方生物等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542788473","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542788473?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 10:35","pubTimestamp":1749609344,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002082","BK0070","BK0077","159992","BK0004","300199","BK1161","002900","BK0188","BK0046","BK0216","301520","002250","06978","159982","399300","BK0050","BK0028","BK0118","BK0229","688382","BK0239","300204","BK1574"],"gpt_icon":0},{"id":"2542706320","title":"李氏大药厂盘中异动 快速上涨5.23%报1.610港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542706320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542706320?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 10:12","pubTimestamp":1749607934,"startTime":"0","endTime":"0","summary":"2025年06月11日早盘10时12分，李氏大药厂股票出现波动，股价大幅拉升5.23%。截至发稿，该股报1.610港元/股，成交量7.7万股，换手率0.01%，振幅1.31%。资金方面，该股资金流入12.385万港元，流出1.256万港元。李氏大药厂股票所在的药品行业中，整体涨幅为0.20%。其相关个股中，联康生物科技集团、九源基因、开拓药业-B涨幅较大，振幅较大的相关个股有九源基因、绿叶制药、先声药业，振幅分别为8.03%、6.61%、6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611101214a702ec81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611101214a702ec81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06622","BK1587","BK1191","BK1574","00950"],"gpt_icon":0},{"id":"2542320026","title":"荣昌生物盘中异动 早盘股价大涨5.01%报50.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542320026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542320026?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 10:11","pubTimestamp":1749607880,"startTime":"0","endTime":"0","summary":"2025年06月11日早盘10时11分，荣昌生物股票出现异动，股价快速拉升5.01%。截至发稿，该股报50.350港元/股，成交量369.066万股，换手率1.77%，振幅5.74%。资金方面，该股资金流入9491.48万港元，流出5282.11万港元。荣昌生物股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，帝王国际投资、科济药业-B、荣昌生物涨幅较大，振幅较大的相关个股有北海康成-B、科济药业-B、中国抗体-B，振幅分别为18.99%、11.65%、10.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506111011209517166a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506111011209517166a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","LU1969619763.USD","09995","LU2328871848.SGD","BK1583"],"gpt_icon":0},{"id":"2542533322","title":"中国抗体-B(03681)上涨6.35%，报2.68元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533322","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542533322?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 09:41","pubTimestamp":1749606118,"startTime":"0","endTime":"0","summary":"6月11日，中国抗体-B盘中上涨6.35%，截至09:41，报2.68元/股，成交1197.41万元。中国抗体制药有限公司专注于研发、生产和商业化基于单克隆抗体的生物制剂来治疗免疫性疾病，其中旗舰产品SM03  是全球首款用于治疗类风湿关节炎的抗CD22单抗药物，正在全速进行商业化进程。截至2024年年报，中国抗体-B营业总收入202.6万元、净利润-1.85亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/11094150994776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1161","03681"],"gpt_icon":0},{"id":"2542819327","title":"开拓药业-B盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542819327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542819327?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 09:33","pubTimestamp":1749605587,"startTime":"0","endTime":"0","summary":"2025年06月11日早盘09时33分，开拓药业-B股票出现异动，股价快速上涨5.30%。截至发稿，该股报1.590港元/股，成交量9.3万股，换手率0.02%，振幅2.65%。开拓药业-B股票所在的药品行业中，整体跌幅为0.09%。其相关个股中，联康生物科技集团、绿叶制药、和黄医药涨幅较大，振幅较大的相关个股有绿叶制药、联康生物科技集团、凯莱英，振幅分别为6.61%、5.56%、4.91%。该公司在皮科领域有两款核心药物KX-826及GT20029。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093307951706d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093307951706d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2542321222","title":"康方生物“双面承压”：抗癌药陷合规风波，临床数据再引争议","url":"https://stock-news.laohu8.com/highlight/detail?id=2542321222","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542321222?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 09:13","pubTimestamp":1749604380,"startTime":"0","endTime":"0","summary":"抗癌药物卡度尼利单抗竟被患者从医药代表手中大量购得？康方生物近期陷入一波未平、一波又起的双重风波。康方生物迅速回应：问题源于公司重庆销售人员伪造研究立项文件及医院伦理批件，以“研究者发起临床研究”名义骗取公司药物，并无偿提供给患者使用。　　合规风波未息，康方与合作伙伴Summit Therapeutics公布的III期临床HARMONi研究顶线结果再掀波澜。　　康方生物创始人夏瑜此前表态将继续推进伊沃西等产品的临床研究，并加速全球开发。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-06-11/doc-inezscvn2738841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BPRC5H50.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","BK1574","LU2488822045.USD","LU0348783233.USD","LU1720050803.USD","09926","LU0348784397.USD","BK1161","IE00B543WZ88.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2542131324","title":"绿谷医药停产阿尔茨海默病治疗药物 三重质疑下的破冰者终陷困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2542131324","media":"新浪证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542131324?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 09:10","pubTimestamp":1749604200,"startTime":"0","endTime":"0","summary":"曾打破全球阿尔茨海默病领域17年无新药上市困局的中国原研药“九期一”，在荣耀与争议中走过五年后，最终按下了停产键。　　2019年11月，绿谷医药的甘露特钠胶囊顶着“全球首个靶向脑肠轴AD新药”的光环，获国家药监局“有条件批准”上市。“有条件批准”要求绿谷继续提交致癌性试验完整报告及长期有效性数据，为药物安全性埋下问号。　　九期一的停产，为中国创新药热潮敲响一记警钟。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-06-11/doc-inezscvn2737623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2542326415","title":"康诺亚-B(02162)、Moonshot Holdings Limited与牵头账簿管理人及联席账簿管理人订立配售及认购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2542326415","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542326415?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 08:13","pubTimestamp":1749600815,"startTime":"0","endTime":"0","summary":"康诺亚-B(02162)发布公告，于2025年6月11日，公司、补足卖方Moons...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02162","BK1583","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2542326184","title":"开源晨会0611丨美图公司、方盛制药、再鼎医药、绿城中国等","url":"https://stock-news.laohu8.com/highlight/detail?id=2542326184","media":"开源证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542326184?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 08:01","pubTimestamp":1749600064,"startTime":"0","endTime":"0","summary":"2024年12月，美图中国内地市场MAU1.71亿，同比基本持平，中国内地以外市场MAU达到9,451万，同比增长21.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611080753a702c5ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611080753a702c5ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1612","01357","BK1555","BK1618","BK1609","LU2125910500.SGD","09688","03900","BK1574","BK1240","BK1613","LU2045819591.USD","BK1095","LU2125910849.SGD","LU2488822045.USD","BK1161","BK1588"],"gpt_icon":1},{"id":"2542632688","title":"【湖南省提前完成年度医保基金清算】 据国家医保局消息，近日，湖南省医保部门宣布，全省15个统筹区提前1个月完成上年度医保基金清算工作，共向3.1万家定点医药机构拨付清算资金92.2亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542632688","media":"金融界","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542632688?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 07:34","pubTimestamp":1749598463,"startTime":"0","endTime":"0","summary":"据国家医保局消息，近日，湖南省医保部门宣布，全省15个统筹区提前1个月完成上年度医保基金清算工作，共向3.1万家定点医药机构拨付清算资金92.2亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/11073450990628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09939","BK1515","BK1161","BK1574","159938"],"gpt_icon":0},{"id":"2542320834","title":"默沙东RSV单抗获FDA批准上市，和誉医药新药、丽珠医药siRNA疗法新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2542320834","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542320834?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 07:03","pubTimestamp":1749596580,"startTime":"0","endTime":"0","summary":"默沙东的RSV单抗获得FDA批准，和誉医药新药上市，丽珠医药的痛风siRNA疗法申报临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093922977a2380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611093922977a2380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","01513","BK1574","02256","BK1191","BK1161","LU2488822045.USD","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":35,"pageCount":9,"totalSize":699,"code":"91000000","status":"200"}]}}